141 related articles for article (PubMed ID: 17967179)
1. A novel activating role of SRC and STAT3 on HGF transcription in human breast cancer cells.
Sam MR; Elliott BE; Mueller CR
Mol Cancer; 2007 Oct; 6():69. PubMed ID: 17967179
[TBL] [Abstract][Full Text] [Related]
2. Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells.
Hung W; Elliott B
J Biol Chem; 2001 Apr; 276(15):12395-403. PubMed ID: 11278729
[TBL] [Abstract][Full Text] [Related]
3. A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells.
Wojcik EJ; Sharifpoor S; Miller NA; Wright TG; Watering R; Tremblay EA; Swan K; Mueller CR; Elliott BE
Oncogene; 2006 May; 25(19):2773-84. PubMed ID: 16407846
[TBL] [Abstract][Full Text] [Related]
4. Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription.
Reisinger K; Kaufmann R; Gille J
J Cell Sci; 2003 Jan; 116(Pt 2):225-38. PubMed ID: 12482909
[TBL] [Abstract][Full Text] [Related]
5. The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer.
Elliott BE; Hung WL; Boag AH; Tuck AB
Can J Physiol Pharmacol; 2002 Feb; 80(2):91-102. PubMed ID: 11934261
[TBL] [Abstract][Full Text] [Related]
6. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
[TBL] [Abstract][Full Text] [Related]
7. Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells.
Vultur A; Cao J; Arulanandam R; Turkson J; Jove R; Greer P; Craig A; Elliott B; Raptis L
Oncogene; 2004 Apr; 23(15):2600-16. PubMed ID: 15007380
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R
Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415
[TBL] [Abstract][Full Text] [Related]
9. c-Src/histone deacetylase 3 interaction is crucial for hepatocyte growth factor dependent decrease of CXCR4 expression in highly invasive breast tumor cells.
Matteucci E; Ridolfi E; Maroni P; Bendinelli P; Desiderio MA
Mol Cancer Res; 2007 Aug; 5(8):833-45. PubMed ID: 17699109
[TBL] [Abstract][Full Text] [Related]
10. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
Xu H; Washington S; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
[TBL] [Abstract][Full Text] [Related]
11. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
[TBL] [Abstract][Full Text] [Related]
12. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
Proietti C; Salatino M; Rosemblit C; Carnevale R; Pecci A; Kornblihtt AR; Molinolo AA; Frahm I; Charreau EH; Schillaci R; Elizalde PV
Mol Cell Biol; 2005 Jun; 25(12):4826-40. PubMed ID: 15923602
[TBL] [Abstract][Full Text] [Related]
13. The human hepatocyte growth factor (HGF) gene is transcriptionally activated by leukemia inhibitory factor through the Stat binding element.
Tomida M; Saito T
Oncogene; 2004 Jan; 23(3):679-86. PubMed ID: 14647442
[TBL] [Abstract][Full Text] [Related]
14. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells.
Yamamoto N; Mammadova G; Song RX; Fukami Y; Sato K
J Cell Sci; 2006 Nov; 119(Pt 22):4623-33. PubMed ID: 17062641
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutation and functional polymorphism of a novel regulatory element in the HGF gene promoter causes its aberrant expression in human breast cancer.
Ma J; DeFrances MC; Zou C; Johnson C; Ferrell R; Zarnegar R
J Clin Invest; 2009 Mar; 119(3):478-91. PubMed ID: 19188684
[TBL] [Abstract][Full Text] [Related]
17. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.
Gray MJ; Zhang J; Ellis LM; Semenza GL; Evans DB; Watowich SS; Gallick GE
Oncogene; 2005 Apr; 24(19):3110-20. PubMed ID: 15735682
[TBL] [Abstract][Full Text] [Related]
18. c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells.
Rahimi N; Hung W; Tremblay E; Saulnier R; Elliott B
J Biol Chem; 1998 Dec; 273(50):33714-21. PubMed ID: 9837958
[TBL] [Abstract][Full Text] [Related]
19. Pyk2 amplifies epidermal growth factor and c-Src-induced Stat3 activation.
Shi CS; Kehrl JH
J Biol Chem; 2004 Apr; 279(17):17224-31. PubMed ID: 14963038
[TBL] [Abstract][Full Text] [Related]
20. Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and beta-catenin/Wnt pathways.
Previdi S; Maroni P; Matteucci E; Broggini M; Bendinelli P; Desiderio MA
Eur J Cancer; 2010 Jun; 46(9):1679-91. PubMed ID: 20350802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
